UBS Raises Price Target on Edwards Lifesciences (EW) Following Strong 3Q Results
Tweet Send to a Friend
UBS reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $203.00 (from $201.00), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
